当前位置:首页 - 行情中心 - 海昇药业(920656) - 财务分析 - 现金流量表

海昇药业

(920656)

  

流通市值:11.27亿  总市值:13.81亿
流通股本:8162.86万   总股本:1.00亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金144,768,406.1893,879,422.7334,916,362138,931,947.93
  收到其他与经营活动有关的现金2,122,594.041,105,500.37545,873.828,317,631.84
  经营活动现金流入小计146,891,000.2294,984,923.135,462,235.82147,249,579.77
  购买商品、接受劳务支付的现金41,888,479.0128,675,979.1212,351,791.954,493,312.97
  支付给职工以及为职工支付的现金26,227,140.4317,203,186.128,807,118.2237,683,370.85
  支付的各项税费27,286,330.8917,784,070.298,417,874.213,199,861.17
  支付其他与经营活动有关的现金5,129,845.293,781,406.31,400,348.886,544,331.88
  经营活动现金流出小计100,531,795.6267,444,641.8330,977,133.2111,920,876.87
  经营活动产生的现金流量净额46,359,204.627,540,281.274,485,102.6235,328,702.9
二、投资活动产生的现金流量:
  取得投资收益收到的现金4,440,684.493,666,868.062,062,125.756,984,077.42
  收到的其他与投资活动有关的现金2,591,000,0002,046,000,0001,000,000,0002,515,000,000
  投资活动现金流入小计2,595,440,684.492,049,666,868.061,002,062,125.752,521,984,077.42
  购建固定资产、无形资产和其他长期资产支付的现金5,796,239.745,606,476.795,372,837.3712,952,404.7
  支付其他与投资活动有关的现金2,736,000,0001,991,000,000945,000,0002,570,000,000
  投资活动现金流出小计2,741,796,239.741,996,606,476.79950,372,837.372,582,952,404.7
  投资活动产生的现金流量净额-146,355,555.2553,060,391.2751,689,288.38-60,968,327.28
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金40,000,00040,000,000-20,000,000
  支付其他与筹资活动有关的现金---19,698,100
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计40,000,00040,000,000-39,698,100
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-40,000,000-40,000,000--39,698,100
四、汇率变动对现金及现金等价物的影响-2,524,482.35-1,573,262.05-732,110.49-696,089.16
五、现金及现金等价物净增加额-142,520,83339,027,410.4955,442,280.51-66,033,813.54
  加:期初现金及现金等价物余额380,610,266.95380,610,266.95380,610,266.95446,644,080.49
  期末现金及现金等价物余额238,089,433.95419,637,677.44436,052,547.46380,610,266.95
补充资料:
  净利润-47,021,107.42-69,456,983.52
  资产减值准备--18,487.22-472,839.65
  固定资产和投资性房地产折旧-8,559,162.95-17,164,612.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-8,559,162.95-17,164,612.59
  无形资产摊销-444,390.06-510,435.5
  长期待摊费用摊销-88,225.02-176,450.04
  公允价值变动损失----216,333
  财务费用-1,897,233.92-696,089.16
  投资损失--3,450,535.06--6,984,077.42
  递延所得税-27,111.8--877,694.43
  其中:递延所得税资产减少-27,111.8--877,694.43
  存货的减少--1,262,347.05--9,946,728.03
  经营性应收项目的减少--23,733,298.18--47,773,503.47
  经营性应付项目的增加--2,619,259.4-10,840,283.23
  其他-418,923.09-1,347,193.45
  现金的期末余额-419,637,677.44-380,610,266.95
  减:现金的期初余额-380,610,266.95-446,644,080.49
  现金及现金等价物的净增加额-39,027,410.49--66,033,813.54
公告日期2026-10-272026-08-202026-04-162026-04-16
审计意见(境内)标准无保留意见
TOP↑